Results 111 to 120 of about 214,292 (293)

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

open access: yesMolecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla   +9 more
wiley   +1 more source

New Hampshire civic health index [PDF]

open access: yes, 2009
The Carsey Institute is participating in a study to examine America\u27s civic health. Led by the Conference on Citizenship (NCoC), America\u27s Civic Health Index is an annual study that measures a wide variety of civic indicators, such as community ...
Dillon, Michele, Rogers, Shannon H.
core   +1 more source

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Keratin 19 (KRT19) is overexpressed in high‐grade serous ovarian cancer with high levels of Kallikrein‐related peptidases (KLK) 4–7 and is associated with poor survival. In vivo analyses demonstrate that elevated KRT19 increases peritoneal tumour burden.
Sophia Bielesch   +13 more
wiley   +1 more source

Analysis of Correlations between the Level of Partnering Relations and their Influence on the Time, Cost, Quality and Safety of Implementation of Construction Projects

open access: yesSelected Scientific Papers: Journal of Civil Engineering, 2014
The present paper uses the developed model of the influence of partnering relations on the time, cost, quality and safety of implementation of construction projects.
Radziszewska-Zielina Elżbieta   +1 more
doaj   +1 more source

Strategic technology alliances by European firms since 1980: questioning integration? [PDF]

open access: yes
This paper evaluates the extent to which private, non-subsidised cooperative agreements in R&D by EU firms has evolved, paying particular attention to the extent to which economic integration may have influenced intra-EU activity relative to extra-EU ...
Narula,Rajneesh
core   +1 more source

Establishment of a humanized patient‐derived xenograft mouse model of high‐grade serous ovarian cancer for preclinical evaluation of combination immunotherapy

open access: yesMolecular Oncology, EarlyView.
We have established a humanized orthotopic patient‐derived xenograft (Hu‐oPDX) mouse model of high‐grade serous ovarian cancer (HGSOC) that recapitulates human tumor–immune interactions. Using combined anti‐PD‐L1/anti‐CD73 immunotherapy, we demonstrate the model's improved biological relevance and enhanced translational value for preclinical ...
Luka Tandaric   +10 more
wiley   +1 more source

Hippo pathway at the crossroads of stemness and therapeutic resistance in breast cancer

open access: yesMolecular Oncology, EarlyView.
Dysregulation of the Hippo pathway drives nuclear accumulation of YAP/TAZ, activating stemness‐related transcriptional programs that sustain breast cancer stemness and fuel therapeutic resistance across subtypes, underscoring Hippo signaling as a targetable vulnerability. Figure created and edited with BioRender.com.
Giulia Schiavoni   +11 more
wiley   +1 more source

Leadership in construction partnering projects [PDF]

open access: yes
In recent years there has been a growing interest in the use of partnering in construction. Central to any successful partnering arrangement is the change in cultural and behavioural characteristics towards mutual trust and understanding. Leadership is
Amaratunga, Dilanthi   +2 more
core  

Engaging Consumers to Improve Ambulatory Care [PDF]

open access: yes, 2012
Presents lessons learned from the experiences of five Aligning Forces for Quality communities in partnering with patients, families, and caregivers to improve ambulatory care, including integrating patient engagement into existing improvement ...

core  

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy